Skip to main content
Caplight Logo









oVRcome

oVRcome

Private
ChristchurchHealthcare & Life Scienceshttps://ovrcome.io

Last Round

Accelerator

Jun 13, 2025

Total Funding Raised

$47,000

Company Overview

oVRcome operates in Healthcare & Life Sciences and is based in Christchurch. Its latest recorded funding round was an Accelerator round in June 2025.

oVRcome is a digital mental health company that provides a virtual reality exposure therapy platform designed to treat anxiety disorders and phobias.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, AR/VR Experiences, Telemedicine, Patient Engagement, AR/VR Hardware

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

oVRcome Comparables

Compare oVRcome with similar companies based on industry and business-model similarity.

oVRcome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PsyTechVR
81%
Alsensia SA
78%
Healium
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

oVRcome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 13, 2025
SeedOct 1, 2022
Pre SeedJul 29, 2022
GrantJul 7, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

oVRcome Investors

Notable investors and investment history

oVRcome investors
InvestorRounds
NZVCPre Seed, Seed
Australia New Zealand Leadership ForumGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 2, 2025

    Added DigiLEAF Inc. from the 3D Art & Animation industry.

  • Oct 2, 2025

    Added Anivacor Capital Ltd as a customer.

Book a demo to see all signals

For institutional investors. Book with your work email.

oVRcome Filings

Explore SEC and related filing metadata, where available.

oVRcome filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about oVRcome's valuation, stock price, and market status.

Is oVRcome a public or private company?

oVRcome is a private company.

What is the current stock price of oVRcome?

oVRcome is a private company, so its shares have no public market price. Caplight tracks oVRcome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is oVRcome worth (valuation)?

Valuation information for oVRcome is not publicly available.

Can I buy oVRcome stock?

oVRcome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was oVRcome's last funding round?

oVRcome's most recent funding round was Accelerator on June 13, 2025.

Who are the main investors in oVRcome?

Key investors in oVRcome include NZVC, Australia New Zealand Leadership Forum.

Will oVRcome IPO soon?

No public IPO plans have been announced for oVRcome.

How can I track oVRcome secondary market activity?

Caplight tracks bids, offers, and trades in oVRcome's shares on secondary markets.

Firmographic Details

HeadquartersChristchurch
Employee Range16
Year Founded2020
Last FundingJun 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?